Beto O'Rourke's sketchiness on large areas of policy seems almost wilful. Yet it is possible to exaggerate his cluelessness
a week into his presidential campaign, Beto O’Rourke is stirring strong emotions. Among the thousands who have flocked to hear the skateboarding, bilingual Texan in the small rallies he has already held in Iowa, Michigan, Ohio, Pennsylvania and New Hampshire, they seem to be largely positive. Youngish, tall and more charismatic than any of his rivals, as he demonstrated during his losing Senate campaign last year, the 46-year-old former congressman is Democratic box office.
Much of this is warranted. Mr O’Rourke is an undistinguished Democratic front-runner and his sketchiness on large areas of policy seems almost wilful. Surely, on the journey of introspection that followed his Texas defeat, during which Mr O’Rourke ate sacred dirt in New Mexico and blogged religiously, he could have found time to form a view on Brexit? Yet he says he has no opinion on it. And he has little more to say on the environmental and other economic policies he claims to prioritise.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Americans to bet $8.5 billion on NCAA's 'March Madness' basketball tournament: reportAbout 47 million people - one in five American adults - are expected to bet a co...
Leer más »
Don't be lured by Facebook's lower stock price, portfolio manager warnsStrategic Wealth Partners' Mark Tepper says Alphabet is a better bet than Facebook.
Leer más »
Pfizer Adds to Big Pharma’s Gene-Therapy Deal StreakPfizer will pay up to $636 million for the rights to gene therapies under development at Vivet Therapeutics, as pharmaceutical companies bet on the ability of these types of treatments to cure intractable diseases.
Leer más »
Biogen loses same Alzheimer’s bet others have lostThe failures of similar drugs in formal trials meant Biogen’s effort was always a long shot. Yet ditching it vaporized $18 bln, or over a quarter, of the biotech’s value. The giant market for a therapy and the fear of missing out lured in both the company and Wall Street.
Leer más »
Bet on higher bond prices after Fed's dovish coo, technician saysBond prices are on the rise this week after the Federal Reserve again sounded a dovish call. They could keep rising, says Todd Gordon of TradingAnalysis.com.
Leer más »
As worries about populism in Europe rise, investors bet on stock market volatilityInvestors are betting on heightened political uncertainty and greater volatility...
Leer más »
The Vision Fund needs more governanceThe Vision Fund has reinvented investing—and become a giant governance headache
Leer más »